Last updated date
ABOUT THIS STUDY
The purpose of the protocol is to assess the initial pharmacokinetic (PK) profile of a single oral dose of GSI-953 to healthy male Japanese subjects and healthy elderly male Japanese subjects.
5-4-12, Kitashinagawa, Shinagawa-ku, 141-0001, Japan
Alzheimer Disease, Healthy
20 + years
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Alzheimer Disease, HealthyStudy GSI-136 in Healthy Young and Healthy Elderly Subjects
- New York, New York
Alzheimer Disease, HealthyStudy Evaluating Safety of GSI 136 in Young and Elderly Japanese Males
Alzheimer Disease, HealthyStudy Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects
- Kitashinagawa, Shinagawa-ku, Tokyo
Alzheimer Disease, HealthyStudy Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953
- 5-4-12, Kitashinagawa, Shinagawa-ku